(3) Other possible benefits such as improvement of ovarian response to FSH stimulation in poor responders, and prevention of premature endogenous gonadotropin surge, as well as lower risk of severe ovarian hyperstimulation syndrome. This evidence concerns the gene BRD2 and ovarian hyperstimulation syndrome.